ArticleFrontiers in immunology2025

Development of caninized anti-CTLA-4 antibody as salvage combination therapy for anti-PD-L1 refractory tumors in dogs.

Naoya Maekawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.